Chakma Justin (CIK 1951238) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-11-14). Recent activity: Buy SPRY (30,000 shares), Sell SPRY (30,000 shares), Sell SPRY (136,380 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-11-14 | ARS Pharmaceuticals, Inc. (SPRY) | Chief Business Officer | Buy | 30,000 | $25,200 |
| 2025-11-14 | ARS Pharmaceuticals, Inc. (SPRY) | Chief Business Officer | Sell | 30,000 | $267,300 |
| 2025-11-14 | ARS Pharmaceuticals, Inc. (SPRY) | Chief Business Officer | Sell | 136,380 | $1.2M |
Source: SEC Form 4 filings · as of 2025-11-14